Pre-operative imaging, surgery and adjuvant therapy for women diagnosed with cancer of the corpus uteri in community practice in the United States

Gynecologic Oncology

Volumn 96, Issue 3, 2005, Pages 741-748

  Trimble, Edward L ^a   Harlan, Linda C ^a   Clegg, Limin X ^a   Stevens, Jennifer L ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

Adjuvant therapy; Corpus uteri; SEER; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; HORMONE; PLATINUM DERIVATIVE; TAXANE DERIVATIVE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL PRACTICE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SARCOMA; TREATMENT OUTCOME; UNITED STATES; UTERUS CANCER;

EID: 13844266789     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.11.041     Document Type: Article

References (19)

1. http://www.cancer.org/docroot/stt/stt_0.asp.
2. J. Prat Prognostic parameters of endometrial carcinoma Hum. Pathol. 35 2004 649 662
3. http://seer.cancer.gov/csr/1975_2000/results_merged/sect_07_corpus_uteri. pdf.
4. M.D. Sherman, and S.S. Devesa Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus Cancer 98 2003 176 186
5. http://seer.cancer.gov/manuals/codeman.pdf.
6. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J. Chronic Dis. 40 1987 373 383
7. U.S.Bureau of the Census. www.census.gov. Washington, DC, U.S. Department of Commerce.
8. American Hospital Association American Hospital Association guide to the health care field 1988 American Hospital Association Chicago, IL
9. B.V. Shah, B.G. Barnwall, and G.S. Bieler SUDAAN 1997 Research Triangle Institute Research Triangle Park, NC
10. R.B. Goldstein, R.L. Bree, and C.B. Benson Evaluation of the woman with postmenopausal bleeding: society of radiologists in ultrasound-sponsored consensus conference statement J. Ultrasound Med. 20 2001 1025 1036
11. R. Manfredi, P. Mirk, and G. Maresca Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning Radiology 231 2004 372 378
12. E.L. Trimble, C. Kosary, and R.C. Park Lymph node sampling and survival in endometrial cancer Gynecol. Oncol. 71 1998 340 343
13. C.L. Creutzberg, W.L. Van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage I endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411
14. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma Gynecol. Oncol. 92 2004 744 751
15. I. Vergote, K. Kjorstad, and V. Abeler A randomized trial of adjuvant protestogen in early endometrial cancer Cancer 64 1989 1011
16. T.C. Randall, and R.J. Kurman Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40 Obstet. Gynecol. 90 1997 434 440
17. M.E. Randall, G. Brunetto, and H. Muss Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: a randomized phase III trial of the gynecologic oncology group Proc. ASCO 22 2 2003 2 [abstract 3]
18. G.F. Fleming, V.L. Brunetto, and A.J. Mundt Randomized trial of doxorubicin plus cisplatin versus doxorubicin plus cisplatin plus paclitaxel in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study Proc. ASCO 202a 2002 [abstract 807]
19. T.C. Randall, and K. Armstrong Differences in treatment and outcome between African-American and white women with endometrial cancer J. Clin. Oncol. 21 2003 4100 4106